Cargando…
Therapeutic trials in adult FSGS: lessons learned and the road forward
Focal segmental glomerulosclerosis (FSGS) is not a specific disease entity but a lesion that primarily targets the podocyte. In a broad sense, the causes of the lesion can be divided into those triggered by a presumed circulating permeability factor, those that occur secondary to a process that migh...
Autores principales: | De Vriese, An S., Wetzels, Jack F., Glassock, Richard J., Sethi, Sanjeev, Fervenza, Fernando C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136112/ https://www.ncbi.nlm.nih.gov/pubmed/34017116 http://dx.doi.org/10.1038/s41581-021-00427-1 |
Ejemplares similares
-
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations
por: Sethi, Sanjeev, et al.
Publicado: (2014) -
Therapeutic approach to FSGS in children
por: Gipson, Debbie S., et al.
Publicado: (2007) -
“Presumed” Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid Therapy
por: Glassock, Richard J., et al.
Publicado: (2021) -
“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023) -
Interplay between Diagnostic Criteria and Prognostic Accuracy in Chronic Kidney Disease
por: Remuzzi, Giuseppe, et al.
Publicado: (2016)